23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Paenibacillus infection with frequent viral coinfection contributes to postinfectious hydrocephalus in Ugandan infants

      1 , 2 , 3 , 4 , 2 , 3 , 5 , 6 , 4 , 5 , 7 , 8 , 9 , 10 , 10 , 9 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 2 , 18 , 19 , 9 , 20 , 21 , 22 , 23 , 2 , 22 , 3 , 24 , 9 , 9 , 25 , 11 , 23 , 26 , 9 , 27 , 9 , 2 , 16 , 28 , 9 , 5 , 7 , 29 , 4 , 30 , 31 , 32 , 29 , 9 , 33 , 34 , 35 , 36 , 2 , 3 , 4 , 5 , 7 , 20 , 37 , 38
      Science Translational Medicine
      American Association for the Advancement of Science (AAAS)

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Postinfectious hydrocephalus (PIH), which often follows neonatal sepsis, is the most common cause of pediatric hydrocephalus worldwide, yet the microbial pathogens underlying this disease remain to be elucidated. Characterization of the microbial agents causing PIH would enable a shift from surgical palliation of cerebrospinal fluid (CSF) accumulation to prevention of the disease. Here, we examined blood and CSF samples collected from 100 consecutive infant cases of PIH and control cases comprising infants with non-postinfectious hydrocephalus in Uganda. Genomic sequencing of samples was undertaken to test for bacterial, fungal, and parasitic DNA; DNA and RNA sequencing was used to identify viruses; and bacterial culture recovery was used to identify potential causative organisms. We found that infection with the bacterium Paenibacillus, together with frequent cytomegalovirus (CMV) coinfection, was associated with PIH in our infant cohort. Assembly of the genome of a facultative anaerobic bacterial isolate recovered from cultures of CSF samples from PIH cases identified a strain of Paenibacillus thiaminolyticus. This strain, designated Mbale, was lethal when injected into mice in contrast to the benign reference Paenibacillus strain. These findings show that an unbiased pan-microbial approach enabled characterization of Paenibacillus in CSF samples from PIH cases, and point toward a pathway of more optimal treatment and prevention for PIH and other proximate neonatal infections.

          Related collections

          Most cited references45

          • Record: found
          • Abstract: found
          • Article: not found

          Detection of four Plasmodium species in blood from humans by 18S rRNA gene subunit-based and species-specific real-time PCR assays.

          There have been reports of increasing numbers of cases of malaria among migrants and travelers. Although microscopic examination of blood smears remains the "gold standard" in diagnosis, this method suffers from insufficient sensitivity and requires considerable expertise. To improve diagnosis, a multiplex real-time PCR was developed. One set of generic primers targeting a highly conserved region of the 18S rRNA gene of the genus Plasmodium was designed; the primer set was polymorphic enough internally to design four species-specific probes for P. falciparum, P. vivax, P. malarie, and P. ovale. Real-time PCR with species-specific probes detected one plasmid copy of P. falciparum, P. vivax, P. malariae, and P. ovale specifically. The same sensitivity was achieved for all species with real-time PCR with the 18S screening probe. Ninety-seven blood samples were investigated. For 66 of them (60 patients), microscopy and real-time PCR results were compared and had a crude agreement of 86% for the detection of plasmodia. Discordant results were reevaluated with clinical, molecular, and sequencing data to resolve them. All nine discordances between 18S screening PCR and microscopy were resolved in favor of the molecular method, as were eight of nine discordances at the species level for the species-specific PCR among the 31 samples positive by both methods. The other 31 blood samples were tested to monitor the antimalaria treatment in seven patients. The number of parasites measured by real-time PCR fell rapidly for six out of seven patients in parallel to parasitemia determined microscopically. This suggests a role of quantitative PCR for the monitoring of patients receiving antimalaria therapy.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Reactivation of Multiple Viruses in Patients with Sepsis

            A current controversy is whether patients with sepsis progress to an immunosuppressed state. We hypothesized that reactivation of latent viruses occurred with prolonged sepsis thereby providing evidence of clinically-relevant immunosuppression and potentially providing a means to serially-monitor patients' immune status. Secondly, if viral loads are markedly elevated, they may contribute to morbidity and mortality. This study determined if reactivation of herpesviruses, polyomaviruses, and the anellovirus TTV occurred in sepsis and correlated with severity. Serial whole blood and plasma samples from 560 critically-ill septic, 161 critically-ill non-septic, and 164 healthy age-matched patients were analyzed by quantitative-polymerase-chain-reaction for cytomegalovirus (CMV), Epstein-Barr (EBV), herpes-simplex (HSV), human herpes virus-6 (HHV-6), and TTV. Polyomaviruses BK and JC were quantitated in urine. Detectable virus was analyzed with respect to secondary fungal and opportunistic bacterial infections, ICU duration, severity of illness, and survival. Patients with protracted sepsis had markedly increased frequency of detectable virus. Cumulative viral DNA detection rates in blood were: CMV (24.2%), EBV (53.2%), HSV (14.1%), HHV-6 (10.4%), and TTV (77.5%). 42.7% of septic patients had presence of two or more viruses. The 50% detection rate for herpesviruses was 5–8 days after sepsis onset. A small subgroup of septic patients had markedly elevated viral loads (>104–106 DNA copies/ml blood) for CMV, EBV, and HSV. Excluding TTV, DNAemia was uncommon in critically-ill non-septic patients and in age-matched healthy controls. Compared to septic patients without DNAemia, septic patients with viremia had increased fungal and opportunistic bacterial infections. Patients with detectable CMV in plasma had higher 90-day mortality compared to CMV-negative patients; p<0.05. Reactivation of latent viruses is common with prolonged sepsis, with frequencies similar to those occurring in transplant patients on immunosuppressive therapy and consistent with development of an immunosuppressive state. Whether reactivated latent viruses contribute to morbidity and mortality in sepsis remains unknown.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction.

              We applied the polymerase chain reaction to detection of the pathogenic protozoan Toxoplasma gondii based on our identification of a 35-fold-repetitive gene (the B1 gene) as a target. Using this procedure, we were able to amplify and detect the DNA of a single organism directly from a crude cell lysate. This level of sensitivity also allowed us to detect the B1 gene from purified DNA samples containing as few as 10 parasites in the presence of 100,000 human leukocytes. This is representative of the maximal cellular infiltration (10(5)/ml) in 1 ml of cerebrospinal fluid obtained from patients with toxoplasmic encephalitis. The B1 gene is present and conserved in all six T. gondii strains tested to date, including two isolates from patients with acquired immunodeficiency syndrome. No signal was detected by using this assay and DNAs from a variety of other organisms, including several which might be found in the central nervous system of an immunocompromised host. This combination of sensitivity and specificity should make detection of the B1 gene based on polymerase chain reaction amplification a very useful method for diagnosis of toxoplasmosis both in immunocompromised hosts and in congenitally infected fetuses.
                Bookmark

                Author and article information

                Contributors
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                (View ORCID Profile)
                Journal
                Science Translational Medicine
                Sci. Transl. Med.
                American Association for the Advancement of Science (AAAS)
                1946-6234
                1946-6242
                September 30 2020
                September 30 2020
                September 30 2020
                September 30 2020
                : 12
                : 563
                : eaba0565
                Affiliations
                [1 ]Department of Biostatistics, Product Development, Genentech Inc., South San Francisco, CA 94080, USA.
                [2 ]Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY 10032, USA.
                [3 ]Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY 10032, USA.
                [4 ]Institute for Personalized Medicine, Department of Biochemistry and Molecular Biology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
                [5 ]Center for Neural Engineering, Pennsylvania State University, University Park, PA 16802, USA.
                [6 ]Department of Medicine, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
                [7 ]Department of Engineering Science and Mechanics, Pennsylvania State University, University Park, PA 16802, USA.
                [8 ]Department of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
                [9 ]CURE Children’s Hospital of Uganda, Plot 97-105, Bugwere Road, P.O. Box 903 Mbale, Uganda.
                [10 ]Department of Pathology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
                [11 ]Department of Pediatrics, Mbarara University of Science and Technology, P.O. Box 1410 Mbarara, Uganda.
                [12 ]Department of Epidemiology, Mbarara University of Science and Technology, P.O. Box 1410, Mbarara, Uganda.
                [13 ]Department of Microbiology, Mbarara University of Science and Technology, P.O. Box 1410 Mbarara, Uganda.
                [14 ]Division of Infectious Disease, Massachusetts Genereal Hospital, Harvard Medical School, 55 Fruit St, GRJ-504, Boston, MA 02114, USA.
                [15 ]Neonatal Unit, Department of Paediatrics and Child Health, Mbale Regional Referral Hospital, Plot 29-33 Pallisa Road, P.O. Box 1966, Mbale, Uganda.
                [16 ]Mbale Clinical Research Institute, Mbale Regional Referral Hospital, Plot 29-33 Pallisa Road, P.O. Box 1966 Mbale, Uganda.
                [17 ]University of Liverpool, Liverpool, L69 3BX, UK.
                [18 ]Biotia, 100 6th avenue, New York, NY 10013, USA.
                [19 ]Division of Pediatric Infectious Disease, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
                [20 ]Center for Infectious Disease Dynamics, Pennsylvania State University, University Park, PA 16802, USA.
                [21 ]Department of Biology, Pennsylvania State University, University Park, PA 16802, USA.
                [22 ]Department of Statistics, Pennsylvania State University, University Park, PA 16802, USA.
                [23 ]Institute for Translational Medicine, University of Liverpool, Liverpool, L12 2AP, UK.
                [24 ]Department of Neuroscience, Washington University School of Medicine, St. Louis, MO 63130, USA.
                [25 ]Division of Neurosurgery, Hospital for Sick Children, University of Toronto, Toronto, Ontario, M5G 1X8, Canada.
                [26 ]Department of Neurological Surgery, Washington University School of Medicine, St. Louis, MO 63130, USA.
                [27 ]Division of Newborn Medicine, Boston Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston MA 02115, USA.
                [28 ]Busitema University, Mbale Campus, Plot 29-33 Pallisa Road, P.O. Box 1966, Mbale, Uganda.
                [29 ]Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
                [30 ]Department of Medicine, Washington University School of Medicine , St. Louis, MO 63130, USA.
                [31 ]Sanyu Research Unit, Liverpool Women’s Hospital, University of Liverpool, Liverpool L8 7SS, UK.
                [32 ]Department of Mechanical Engineering, Pennsylvania State University, University Park, PA 16802, USA.
                [33 ]National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA.
                [34 ]Université Paris-Saclay, INRAE, MGP, Jouy-en-Josas, 78350, France.
                [35 ]Department of Comparative Medicine, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
                [36 ]Department of Neurosurgery, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA.
                [37 ]Department of Neurosurgery, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
                [38 ]Department of Physics, Pennsylvania State University, University Park, PA 16802, USA.
                Article
                10.1126/scitranslmed.aba0565
                7774825
                32998967
                035a16b3-559a-4cf4-b599-480e0f18a944
                © 2020

                https://www.sciencemag.org/about/science-licenses-journal-article-reuse

                History

                Comments

                Comment on this article